These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8553782)
1. [The production of hybridomas producing monoclonal antibodies to the causative agent of melioidosis by using antigen-stimulated lymphocytes in an in-vitro system]. Titova NG; Razina IV; Sviridov VV; Iakovleva IV; Khrapova NP; Kulakov MIa Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):82-3. PubMed ID: 8553782 [No Abstract] [Full Text] [Related]
2. Monoclonal antibodies to Pseudomonas pseudomallei and their potential for diagnosis of melioidosis. Rugdech P; Anuntagool N; Sirisinha S Am J Trop Med Hyg; 1995 Mar; 52(3):231-5. PubMed ID: 7535014 [TBL] [Abstract][Full Text] [Related]
3. Seropositivity to Burkholderia pseudomallei does not reflect the development of cell-mediated immunity. Lazzaroni SM; Barnes JL; Williams NL; Govan BL; Norton RE; LaBrooy JT; Ketheesan N Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S66-70. PubMed ID: 19121692 [TBL] [Abstract][Full Text] [Related]
4. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. Jones SM; Ellis JF; Russell P; Griffin KF; Oyston PCF J Med Microbiol; 2002 Dec; 51(12):1055-1062. PubMed ID: 12466403 [TBL] [Abstract][Full Text] [Related]
5. Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens. Barnes JL; Ketheesan N Immunol Cell Biol; 2007 Oct; 85(7):551-7. PubMed ID: 17563759 [TBL] [Abstract][Full Text] [Related]
6. Rapid identification of Burkholderia pseudomallei in blood cultures by latex agglutination using lipopolysaccharide-specific monoclonal antibody. Dharakul T; Songsivilai S; Smithikarn S; Thepthai C; Leelaporn A Am J Trop Med Hyg; 1999 Oct; 61(4):658-62. PubMed ID: 10548306 [TBL] [Abstract][Full Text] [Related]
8. Analysis of peptide mimotopes of Burkholderia pseudomallei exopolysaccharide. Legutki JB; Nelson M; Titball R; Galloway DR; Mateczun A; Baillie LW Vaccine; 2007 Nov; 25(45):7796-805. PubMed ID: 17935838 [TBL] [Abstract][Full Text] [Related]
9. In vitro immunization for the production of antigen-specific lymphocyte hybridomas. Borrebaeck CA Scand J Immunol; 1983 Jul; 18(1):9-12. PubMed ID: 6192490 [TBL] [Abstract][Full Text] [Related]
10. Production and characterization of chimeric monoclonal antibodies against Burkholderia pseudomallei and B. mallei using the DHFR expression system. Kim HY; Tsai S; Lo SC; Wear DJ; Izadjoo MJ PLoS One; 2011 May; 6(5):e19867. PubMed ID: 21573027 [TBL] [Abstract][Full Text] [Related]
11. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents. Druar C; Yu F; Barnes JL; Okinaka RT; Chantratita N; Beg S; Stratilo CW; Olive AJ; Soltes G; Russell ML; Limmathurotsakul D; Norton RE; Ni SX; Picking WD; Jackson PJ; Stewart DI; Tsvetnitsky V; Picking WL; Cherwonogrodzky JW; Ketheesan N; Peacock SJ; Wiersma EJ FEMS Immunol Med Microbiol; 2008 Jan; 52(1):78-87. PubMed ID: 17995960 [TBL] [Abstract][Full Text] [Related]
12. Relationship between antigenicity and pathogenicity for Burkholderia pseudomallei and Burkholderia mallei revealed by a large panel of mouse MAbs. Zou N; Tsai S; Feng SH; Newsome T; Kim HY; Li B; Zhang S; Lo SC Hybridoma (Larchmt); 2008 Aug; 27(4):231-40. PubMed ID: 18707541 [TBL] [Abstract][Full Text] [Related]
13. Development of Immunoassays for Nualnoi T; Norris MH; Tuanyok A; Brett PJ; Burtnick MN; Keim PS; Settles EW; Allender CJ; AuCoin DP Am J Trop Med Hyg; 2017 Feb; 96(2):358-367. PubMed ID: 27994103 [No Abstract] [Full Text] [Related]
16. Development of mouse hybridomas for production of monoclonal antibodies specific to Burkholderia mallei and Burkholderia pseudomallei. Feng SH; Tsai S; Rodriguez J; Newsome T; Emanuel P; Lo SC Hybridoma (Larchmt); 2006 Aug; 25(4):193-201. PubMed ID: 16934015 [TBL] [Abstract][Full Text] [Related]
17. [The outlook for improving the immunoglobulin preparations for the detection and identification of the causative agents of glanders and melioidosis]. Khrapova NP; Tikhonov NG; Prokhvatilova EV; Kulakov MIa Med Parazitol (Mosk); 1995; (4):49-53. PubMed ID: 8587520 [TBL] [Abstract][Full Text] [Related]
18. [Generation and characteristics of hybridomas producing monoclonal antibodies to the surface antigen of hepatitis B virus]. Kushch AA; Momot AM; Shumaĭ EP; Bukrinskaia AG; Anan'ev VA Vopr Virusol; 1987; 32(4):448-51. PubMed ID: 3318133 [TBL] [Abstract][Full Text] [Related]
19. Serodiagnosis of melioidosis by a competitive enzyme-linked immunosorbent assay using a lipopolysaccharide-specific monoclonal antibody. Thepthai C; Smithtikarn S; Suksuwan M; Songsivilai S; Dharakul T Asian Pac J Allergy Immunol; 2005; 23(2-3):127-32. PubMed ID: 16252843 [TBL] [Abstract][Full Text] [Related]
20. [Immunogenic potential of glanders and melioidosis agents]. Kalachev II; Baídus' AN; Ivanova OA; Ganina EA; Boldyrev IA; Svetoch EA Vestn Ross Akad Med Nauk; 1997; (6):32-7. PubMed ID: 9289277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]